论文部分内容阅读
目的探讨顺铂联合紫杉醇脂质体治疗晚期非小细胞肺癌的近期疗效及不良反应。方法顺铂联合紫杉醇脂质体对74例晚期非小细胞肺癌患者进行治疗。结果患者完全缓解4例、部分缓解30例、稳定28例、进展12例。所有患者均未发生过敏反应,发生不良反应的程度较轻。结论采用顺铂联合紫杉醇脂质体对晚期非小细胞肺癌进行治疗具有较好的疗效,不良反应较轻,值得临床进一步推广应用。
Objective To investigate the short-term efficacy and side effects of cisplatin combined with paclitaxel liposomes in the treatment of advanced non-small cell lung cancer. Methods 74 cases of advanced non-small cell lung cancer were treated with cisplatin and paclitaxel liposomes. Results The patients were completely relieved in 4 cases, partially relieved in 30 cases, stabilized in 28 cases, and progressed in 12 cases. All patients had no allergic reactions, the extent of adverse reactions occurred less. Conclusion The combination of cisplatin and paclitaxel liposomes has a good curative effect in the treatment of advanced non-small cell lung cancer with less adverse reactions, which deserves further clinical application.